DuPont de Nemours Inc's stock soared 9.47% during intraday trading on Tuesday, driven by the company's robust first-quarter 2026 financial results and an optimistic raised outlook for the full year.

The industrial materials maker reported quarterly adjusted earnings per share of $0.55, significantly beating the analyst consensus estimate of $0.48. Quarterly sales reached $1.681 billion, also exceeding expectations. The company raised its full-year 2026 adjusted earnings forecast to a range of $2.35 to $2.40 per share, up from its previous guidance, and increased its net sales outlook. Furthermore, DuPont announced the imminent launch of a $275 million accelerated share repurchase program.

The strong performance was attributed to effective price increases that offset higher input costs driven by Middle East geopolitical tensions, as well as gains from the recent sale of its Aramids business. The company's Healthcare & Water Technologies segment saw sales rise 5.6%, while the Diversified Industrials unit posted a 3% increase, demonstrating resilience across its portfolio.